DJIA 16,102.38 -272.38 -1.66%
NASDAQ 4,683.92 -49.58 -1.05%
S&P 500 1,921.22 -29.91 -1.53%
market minute promo

MannKind Corp (NASDAQ: MNKD)



company name or ticker

MNKD September 4th Options Begin Trading

The Future Of MannKind

The Most Important Question For Celgene Investors After The Receptos Acquisition

If Afrezza Isn't A Blockbuster Is MannKind Doomed?

MannKind: Decision Time Regarding Those Convertible Bonds

Is A Long Position In Sanofi Worth The Risk?

MannKind's Afrezza: An Expensive Failure

Short-Sellers Betting Against These Biotechs

The Reason MannKind Stock Galloped 10% Higher in June

MannKind shareholders are breathing easier after a double-digit percentage gain in June, but are its share price gains sustainable?

PSA: Afrezza Is NOT Exubera

See More Articles...